Spiriva is covered by 69 percent of Medicare Prescription drug plans.
Most health insurance and Medicare prescription drug plans cover Spiriva Handihaler and Spiriva Respimat inhalation powder.
And some insurance plans may apply restrictions.
Both Spiriva products are typically grouped under higher-copay brand-name drug tiers.
If you're uninsured or underinsured, you may be eligible for the Spiriva HandiHaler or Spiriva Respimat patient assistance programs, which offer the medications at no charge.
Without insurance, the average cash price for a single Spiriva Respimat inhaler is $620.00
A single inhaler provides 60 actuations, enough medicine for 30 days.
That means the average price per day of treatment is around $20.00
Spiriva is a medication that belongs to a group of drugs called anticholinergics.
These drugs treat asthma and COPD by keeping your airways open.
Other anticholinergic drugs used for COPD include ipratropium (Atrovent HFA) and revefenacin (Yupelri).
SPIRIVA RESPIMAT, 2.5 mcg, is a long-term, once-daily, prescription medicine used to control symptoms of chronic obstructive pulmonary disease (COPD) by relaxing your airways and keeping them open.
COPD includes chronic bronchitis and emphysema.
The most common side effects reported with SPIRIVA HANDIHALER in people with COPD include upper respiratory tract infection, dry mouth, sinus infection, sore throat, non-specific chest pain, urinary tract infection, indigestion, runny nose, constipation, increased heart rate, and blurred vision.